Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells

CD19 is overexpressed in most human B cell malignancies and considered an important tumor marker for diagnosis and treatment. Aptamers are oligonucleotides that may potentially serve as tumor-homing ligand for targeted cancer therapy with excellent affinity and specificity. In this study, we selecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yan, Li, Xiaoou, An, Yacong, Duan, Jinhong, Yang, Xian-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003574/
https://www.ncbi.nlm.nih.gov/pubmed/29928472
http://dx.doi.org/10.18632/oncotarget.24902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6003574/
https://www.ncbi.nlm.nih.gov/pubmed/29928472
http://dx.doi.org/10.18632/oncotarget.24902

Ejemplares similares